Generation and Validation of the Patient-Reported Outcome Measurement Information System Itch Questionnaire–Child (PIQ-C) to Measure the Impact of Itch on Life Quality-Reference-Cited by-同舟云学术

Generation and Validation of the Patient-Reported Outcome Measurement Information System Itch Questionnaire–Child (PIQ-C) to Measure the Impact of Itch on Life Quality

Published:2021-10 Issue: Volume: Page:
ISSN:0022-202X
Container-title:Journal of Investigative Dermatology
language:en
Short-container-title:Journal of Investigative Dermatology

Author:

Paller Amy S.^ORCID,Lai Jin-Shei^ORCID,Jackson Kathryn^ORCID,Rangel Stephanie M.^ORCID,Nowinski Cindy^ORCID,Silverberg Jonathan I.^ORCID,Ustsinovich Vitali^ORCID,Cella David^ORCID

Funder

National Institutes of Health

National Center for Advancing Translational Sciences

Publisher

Elsevier BV

Subject

Cell Biology,Dermatology,Molecular Biology,Biochemistry

Reference34 articles.

1. The burden of moderate to severe atopic dermatitis in Canadian children: a cross-sectional survey;Bridgman;J Cutan Med Surg,2018

2. The future of outcomes measurement: item banking, tailored short-forms, and computerized adaptive assessment;Cella;Qual Life Res,2007

3. Translating patient-oriented eczema measure (POEM) scores into clinical practice by suggesting severity strata derived using anchor-based methods;Charman;Br J Dermatol,2013

4. Association of pediatric atopic dermatitis and psoriasis with school absenteeism and parental work absenteeism: a cross-sectional United States population-based study;Cheng;J Am Acad Dermatol,2021

5. Consensus conference on pediatric atopic dermatitis;Eichenfield;J Am Acad Dermatol,2003

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Belastung durch gestörten Schlaf und dessen Verbesserung durch topische Behandlung bei Psoriasis und atopischer Dermatitis;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2024-05

2. Burden of impaired sleep and its improvement through topical treatment in psoriasis and atopic dermatitis;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2024-04-18

3. Improved patient‐ and caregiver‐reported outcomes distinguish tacrolimus 0.03% from crisaborole in children with atopic dermatitis;Journal of the European Academy of Dermatology and Venereology;2024-02-15

4. A Comprehensive Review of Evaluating Donor Site Morbidity and Scar Outcomes in Skin Transfer Techniques;Cureus;2024-02-01

5. Do socioeconomic factors impact atopic dermatitis outcome? A single‐center study;Pediatric Dermatology;2023-10-10